Global Pulmonary Drug Delivery Devices & Systems Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Page: 99
Published Date: 02 Jan 2024
Category: Medical Devices & Consumables
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global Pulmonary Drug Delivery Devices & Systems market size was valued at USD 3134.3 million in 2023 and is forecast to a readjusted size of USD 4050.8 million by 2030 with a CAGR of 3.7% during review period.
Pulmonary Drug Delivery Devices/Systems include metered dose inhalers,dry powder inhalers,nebulizers and accessories.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Pulmonary Drug Delivery Devices & Systems industry chain, the market status of Hospitals and Clinics (Metered Dose Inhalers, Dry Powder Inhalers), Homecare (Metered Dose Inhalers, Dry Powder Inhalers), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Pulmonary Drug Delivery Devices & Systems.
Regionally, the report analyzes the Pulmonary Drug Delivery Devices & Systems markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Pulmonary Drug Delivery Devices & Systems market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Pulmonary Drug Delivery Devices & Systems market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Pulmonary Drug Delivery Devices & Systems industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Metered Dose Inhalers, Dry Powder Inhalers).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Pulmonary Drug Delivery Devices & Systems market.
Regional Analysis: The report involves examining the Pulmonary Drug Delivery Devices & Systems market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Pulmonary Drug Delivery Devices & Systems market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Pulmonary Drug Delivery Devices & Systems:
Company Analysis: Report covers individual Pulmonary Drug Delivery Devices & Systems manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Pulmonary Drug Delivery Devices & Systems This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals and Clinics, Homecare).
Technology Analysis: Report covers specific technologies relevant to Pulmonary Drug Delivery Devices & Systems. It assesses the current state, advancements, and potential future developments in Pulmonary Drug Delivery Devices & Systems areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Pulmonary Drug Delivery Devices & Systems market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Pulmonary Drug Delivery Devices & Systems market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Metered Dose Inhalers
Dry Powder Inhalers
Nebulizers
Accessories
Market segment by Application
Hospitals and Clinics
Homecare
Major players covered
Hovione
3M Health Care
Bespak
BeyonDevices
GlaxoSmithKline
H&T Presspart
PARI Respiratory Equipment
Philips Respironics
SHL
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pulmonary Drug Delivery Devices & Systems product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Pulmonary Drug Delivery Devices & Systems, with price, sales, revenue and global market share of Pulmonary Drug Delivery Devices & Systems from 2019 to 2024.
Chapter 3, the Pulmonary Drug Delivery Devices & Systems competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pulmonary Drug Delivery Devices & Systems breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Pulmonary Drug Delivery Devices & Systems market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Pulmonary Drug Delivery Devices & Systems.
Chapter 14 and 15, to describe Pulmonary Drug Delivery Devices & Systems sales channel, distributors, customers, research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Pulmonary Drug Delivery Devices & Systems
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Pulmonary Drug Delivery Devices & Systems Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Metered Dose Inhalers
1.3.3 Dry Powder Inhalers
1.3.4 Nebulizers
1.3.5 Accessories
1.4 Market Analysis by Application
1.4.1 Overview: Global Pulmonary Drug Delivery Devices & Systems Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals and Clinics
1.4.3 Homecare
1.5 Global Pulmonary Drug Delivery Devices & Systems Market Size & Forecast
1.5.1 Global Pulmonary Drug Delivery Devices & Systems Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Pulmonary Drug Delivery Devices & Systems Sales Quantity (2019-2030)
1.5.3 Global Pulmonary Drug Delivery Devices & Systems Average Price (2019-2030)
2.1 Hovione
2.1.1 Hovione Details
2.1.2 Hovione Major Business
2.1.3 Hovione Pulmonary Drug Delivery Devices & Systems Product and Services
2.1.4 Hovione Pulmonary Drug Delivery Devices & Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Hovione Recent Developments/Updates
2.2 3M Health Care
2.2.1 3M Health Care Details
2.2.2 3M Health Care Major Business
2.2.3 3M Health Care Pulmonary Drug Delivery Devices & Systems Product and Services
2.2.4 3M Health Care Pulmonary Drug Delivery Devices & Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 3M Health Care Recent Developments/Updates
2.3 Bespak
2.3.1 Bespak Details
2.3.2 Bespak Major Business
2.3.3 Bespak Pulmonary Drug Delivery Devices & Systems Product and Services
2.3.4 Bespak Pulmonary Drug Delivery Devices & Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Bespak Recent Developments/Updates
2.4 BeyonDevices
2.4.1 BeyonDevices Details
2.4.2 BeyonDevices Major Business
2.4.3 BeyonDevices Pulmonary Drug Delivery Devices & Systems Product and Services
2.4.4 BeyonDevices Pulmonary Drug Delivery Devices & Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 BeyonDevices Recent Developments/Updates
2.5 GlaxoSmithKline
2.5.1 GlaxoSmithKline Details
2.5.2 GlaxoSmithKline Major Business
2.5.3 GlaxoSmithKline Pulmonary Drug Delivery Devices & Systems Product and Services
2.5.4 GlaxoSmithKline Pulmonary Drug Delivery Devices & Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 GlaxoSmithKline Recent Developments/Updates
2.6 H&T Presspart
2.6.1 H&T Presspart Details
2.6.2 H&T Presspart Major Business
2.6.3 H&T Presspart Pulmonary Drug Delivery Devices & Systems Product and Services
2.6.4 H&T Presspart Pulmonary Drug Delivery Devices & Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 H&T Presspart Recent Developments/Updates
2.7 PARI Respiratory Equipment
2.7.1 PARI Respiratory Equipment Details
2.7.2 PARI Respiratory Equipment Major Business
2.7.3 PARI Respiratory Equipment Pulmonary Drug Delivery Devices & Systems Product and Services
2.7.4 PARI Respiratory Equipment Pulmonary Drug Delivery Devices & Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 PARI Respiratory Equipment Recent Developments/Updates
2.8 Philips Respironics
2.8.1 Philips Respironics Details
2.8.2 Philips Respironics Major Business
2.8.3 Philips Respironics Pulmonary Drug Delivery Devices & Systems Product and Services
2.8.4 Philips Respironics Pulmonary Drug Delivery Devices & Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Philips Respironics Recent Developments/Updates
2.9 SHL
2.9.1 SHL Details
2.9.2 SHL Major Business
2.9.3 SHL Pulmonary Drug Delivery Devices & Systems Product and Services
2.9.4 SHL Pulmonary Drug Delivery Devices & Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 SHL Recent Developments/Updates
3.1 Global Pulmonary Drug Delivery Devices & Systems Sales Quantity by Manufacturer (2019-2024)
3.2 Global Pulmonary Drug Delivery Devices & Systems Revenue by Manufacturer (2019-2024)
3.3 Global Pulmonary Drug Delivery Devices & Systems Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Pulmonary Drug Delivery Devices & Systems by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Pulmonary Drug Delivery Devices & Systems Manufacturer Market Share in 2023
3.4.2 Top 6 Pulmonary Drug Delivery Devices & Systems Manufacturer Market Share in 2023
3.5 Pulmonary Drug Delivery Devices & Systems Market: Overall Company Footprint Analysis
3.5.1 Pulmonary Drug Delivery Devices & Systems Market: Region Footprint
3.5.2 Pulmonary Drug Delivery Devices & Systems Market: Company Product Type Footprint
3.5.3 Pulmonary Drug Delivery Devices & Systems Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Pulmonary Drug Delivery Devices & Systems Market Size by Region
4.1.1 Global Pulmonary Drug Delivery Devices & Systems Sales Quantity by Region (2019-2030)
4.1.2 Global Pulmonary Drug Delivery Devices & Systems Consumption Value by Region (2019-2030)
4.1.3 Global Pulmonary Drug Delivery Devices & Systems Average Price by Region (2019-2030)
4.2 North America Pulmonary Drug Delivery Devices & Systems Consumption Value (2019-2030)
4.3 Europe Pulmonary Drug Delivery Devices & Systems Consumption Value (2019-2030)
4.4 Asia-Pacific Pulmonary Drug Delivery Devices & Systems Consumption Value (2019-2030)
4.5 South America Pulmonary Drug Delivery Devices & Systems Consumption Value (2019-2030)
4.6 Middle East and Africa Pulmonary Drug Delivery Devices & Systems Consumption Value (2019-2030)
5.1 Global Pulmonary Drug Delivery Devices & Systems Sales Quantity by Type (2019-2030)
5.2 Global Pulmonary Drug Delivery Devices & Systems Consumption Value by Type (2019-2030)
5.3 Global Pulmonary Drug Delivery Devices & Systems Average Price by Type (2019-2030)
6.1 Global Pulmonary Drug Delivery Devices & Systems Sales Quantity by Application (2019-2030)
6.2 Global Pulmonary Drug Delivery Devices & Systems Consumption Value by Application (2019-2030)
6.3 Global Pulmonary Drug Delivery Devices & Systems Average Price by Application (2019-2030)
7.1 North America Pulmonary Drug Delivery Devices & Systems Sales Quantity by Type (2019-2030)
7.2 North America Pulmonary Drug Delivery Devices & Systems Sales Quantity by Application (2019-2030)
7.3 North America Pulmonary Drug Delivery Devices & Systems Market Size by Country
7.3.1 North America Pulmonary Drug Delivery Devices & Systems Sales Quantity by Country (2019-2030)
7.3.2 North America Pulmonary Drug Delivery Devices & Systems Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8.1 Europe Pulmonary Drug Delivery Devices & Systems Sales Quantity by Type (2019-2030)
8.2 Europe Pulmonary Drug Delivery Devices & Systems Sales Quantity by Application (2019-2030)
8.3 Europe Pulmonary Drug Delivery Devices & Systems Market Size by Country
8.3.1 Europe Pulmonary Drug Delivery Devices & Systems Sales Quantity by Country (2019-2030)
8.3.2 Europe Pulmonary Drug Delivery Devices & Systems Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9.1 Asia-Pacific Pulmonary Drug Delivery Devices & Systems Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Pulmonary Drug Delivery Devices & Systems Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Pulmonary Drug Delivery Devices & Systems Market Size by Region
9.3.1 Asia-Pacific Pulmonary Drug Delivery Devices & Systems Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Pulmonary Drug Delivery Devices & Systems Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10.1 South America Pulmonary Drug Delivery Devices & Systems Sales Quantity by Type (2019-2030)
10.2 South America Pulmonary Drug Delivery Devices & Systems Sales Quantity by Application (2019-2030)
10.3 South America Pulmonary Drug Delivery Devices & Systems Market Size by Country
10.3.1 South America Pulmonary Drug Delivery Devices & Systems Sales Quantity by Country (2019-2030)
10.3.2 South America Pulmonary Drug Delivery Devices & Systems Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11.1 Middle East & Africa Pulmonary Drug Delivery Devices & Systems Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Pulmonary Drug Delivery Devices & Systems Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Pulmonary Drug Delivery Devices & Systems Market Size by Country
11.3.1 Middle East & Africa Pulmonary Drug Delivery Devices & Systems Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Pulmonary Drug Delivery Devices & Systems Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12.1 Pulmonary Drug Delivery Devices & Systems Market Drivers
12.2 Pulmonary Drug Delivery Devices & Systems Market Restraints
12.3 Pulmonary Drug Delivery Devices & Systems Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13.1 Raw Material of Pulmonary Drug Delivery Devices & Systems and Key Manufacturers
13.2 Manufacturing Costs Percentage of Pulmonary Drug Delivery Devices & Systems
13.3 Pulmonary Drug Delivery Devices & Systems Production Process
13.4 Pulmonary Drug Delivery Devices & Systems Industrial Chain
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Pulmonary Drug Delivery Devices & Systems Typical Distributors
14.3 Pulmonary Drug Delivery Devices & Systems Typical Customers
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Pulmonary Drug Delivery Devices & Systems Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Pulmonary Drug Delivery Devices & Systems Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Hovione Basic Information, Manufacturing Base and Competitors
Table 4. Hovione Major Business
Table 5. Hovione Pulmonary Drug Delivery Devices & Systems Product and Services
Table 6. Hovione Pulmonary Drug Delivery Devices & Systems Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Hovione Recent Developments/Updates
Table 8. 3M Health Care Basic Information, Manufacturing Base and Competitors
Table 9. 3M Health Care Major Business
Table 10. 3M Health Care Pulmonary Drug Delivery Devices & Systems Product and Services
Table 11. 3M Health Care Pulmonary Drug Delivery Devices & Systems Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. 3M Health Care Recent Developments/Updates
Table 13. Bespak Basic Information, Manufacturing Base and Competitors
Table 14. Bespak Major Business
Table 15. Bespak Pulmonary Drug Delivery Devices & Systems Product and Services
Table 16. Bespak Pulmonary Drug Delivery Devices & Systems Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Bespak Recent Developments/Updates
Table 18. BeyonDevices Basic Information, Manufacturing Base and Competitors
Table 19. BeyonDevices Major Business
Table 20. BeyonDevices Pulmonary Drug Delivery Devices & Systems Product and Services
Table 21. BeyonDevices Pulmonary Drug Delivery Devices & Systems Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. BeyonDevices Recent Developments/Updates
Table 23. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 24. GlaxoSmithKline Major Business
Table 25. GlaxoSmithKline Pulmonary Drug Delivery Devices & Systems Product and Services
Table 26. GlaxoSmithKline Pulmonary Drug Delivery Devices & Systems Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. GlaxoSmithKline Recent Developments/Updates
Table 28. H&T Presspart Basic Information, Manufacturing Base and Competitors
Table 29. H&T Presspart Major Business
Table 30. H&T Presspart Pulmonary Drug Delivery Devices & Systems Product and Services
Table 31. H&T Presspart Pulmonary Drug Delivery Devices & Systems Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. H&T Presspart Recent Developments/Updates
Table 33. PARI Respiratory Equipment Basic Information, Manufacturing Base and Competitors
Table 34. PARI Respiratory Equipment Major Business
Table 35. PARI Respiratory Equipment Pulmonary Drug Delivery Devices & Systems Product and Services
Table 36. PARI Respiratory Equipment Pulmonary Drug Delivery Devices & Systems Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. PARI Respiratory Equipment Recent Developments/Updates
Table 38. Philips Respironics Basic Information, Manufacturing Base and Competitors
Table 39. Philips Respironics Major Business
Table 40. Philips Respironics Pulmonary Drug Delivery Devices & Systems Product and Services
Table 41. Philips Respironics Pulmonary Drug Delivery Devices & Systems Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Philips Respironics Recent Developments/Updates
Table 43. SHL Basic Information, Manufacturing Base and Competitors
Table 44. SHL Major Business
Table 45. SHL Pulmonary Drug Delivery Devices & Systems Product and Services
Table 46. SHL Pulmonary Drug Delivery Devices & Systems Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. SHL Recent Developments/Updates
Table 48. Global Pulmonary Drug Delivery Devices & Systems Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 49. Global Pulmonary Drug Delivery Devices & Systems Revenue by Manufacturer (2019-2024) & (USD Million)
Table 50. Global Pulmonary Drug Delivery Devices & Systems Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 51. Market Position of Manufacturers in Pulmonary Drug Delivery Devices & Systems, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 52. Head Office and Pulmonary Drug Delivery Devices & Systems Production Site of Key Manufacturer
Table 53. Pulmonary Drug Delivery Devices & Systems Market: Company Product Type Footprint
Table 54. Pulmonary Drug Delivery Devices & Systems Market: Company Product Application Footprint
Table 55. Pulmonary Drug Delivery Devices & Systems New Market Entrants and Barriers to Market Entry
Table 56. Pulmonary Drug Delivery Devices & Systems Mergers, Acquisition, Agreements, and Collaborations
Table 57. Global Pulmonary Drug Delivery Devices & Systems Sales Quantity by Region (2019-2024) & (K Units)
Table 58. Global Pulmonary Drug Delivery Devices & Systems Sales Quantity by Region (2025-2030) & (K Units)
Table 59. Global Pulmonary Drug Delivery Devices & Systems Consumption Value by Region (2019-2024) & (USD Million)
Table 60. Global Pulmonary Drug Delivery Devices & Systems Consumption Value by Region (2025-2030) & (USD Million)
Table 61. Global Pulmonary Drug Delivery Devices & Systems Average Price by Region (2019-2024) & (USD/Unit)
Table 62. Global Pulmonary Drug Delivery Devices & Systems Average Price by Region (2025-2030) & (USD/Unit)
Table 63. Global Pulmonary Drug Delivery Devices & Systems Sales Quantity by Type (2019-2024) & (K Units)
Table 64. Global Pulmonary Drug Delivery Devices & Systems Sales Quantity by Type (2025-2030) & (K Units)
Table 65. Global Pulmonary Drug Delivery Devices & Systems Consumption Value by Type (2019-2024) & (USD Million)
Table 66. Global Pulmonary Drug Delivery Devices & Systems Consumption Value by Type (2025-2030) & (USD Million)
Table 67. Global Pulmonary Drug Delivery Devices & Systems Average Price by Type (2019-2024) & (USD/Unit)
Table 68. Global Pulmonary Drug Delivery Devices & Systems Average Price by Type (2025-2030) & (USD/Unit)
Table 69. Global Pulmonary Drug Delivery Devices & Systems Sales Quantity by Application (2019-2024) & (K Units)
Table 70. Global Pulmonary Drug Delivery Devices & Systems Sales Quantity by Application (2025-2030) & (K Units)
Table 71. Global Pulmonary Drug Delivery Devices & Systems Consumption Value by Application (2019-2024) & (USD Million)
Table 72. Global Pulmonary Drug Delivery Devices & Systems Consumption Value by Application (2025-2030) & (USD Million)
Table 73. Global Pulmonary Drug Delivery Devices & Systems Average Price by Application (2019-2024) & (USD/Unit)
Table 74. Global Pulmonary Drug Delivery Devices & Systems Average Price by Application (2025-2030) & (USD/Unit)
Table 75. North America Pulmonary Drug Delivery Devices & Systems Sales Quantity by Type (2019-2024) & (K Units)
Table 76. North America Pulmonary Drug Delivery Devices & Systems Sales Quantity by Type (2025-2030) & (K Units)
Table 77. North America Pulmonary Drug Delivery Devices & Systems Sales Quantity by Application (2019-2024) & (K Units)
Table 78. North America Pulmonary Drug Delivery Devices & Systems Sales Quantity by Application (2025-2030) & (K Units)
Table 79. North America Pulmonary Drug Delivery Devices & Systems Sales Quantity by Country (2019-2024) & (K Units)
Table 80. North America Pulmonary Drug Delivery Devices & Systems Sales Quantity by Country (2025-2030) & (K Units)
Table 81. North America Pulmonary Drug Delivery Devices & Systems Consumption Value by Country (2019-2024) & (USD Million)
Table 82. North America Pulmonary Drug Delivery Devices & Systems Consumption Value by Country (2025-2030) & (USD Million)
Table 83. Europe Pulmonary Drug Delivery Devices & Systems Sales Quantity by Type (2019-2024) & (K Units)
Table 84. Europe Pulmonary Drug Delivery Devices & Systems Sales Quantity by Type (2025-2030) & (K Units)
Table 85. Europe Pulmonary Drug Delivery Devices & Systems Sales Quantity by Application (2019-2024) & (K Units)
Table 86. Europe Pulmonary Drug Delivery Devices & Systems Sales Quantity by Application (2025-2030) & (K Units)
Table 87. Europe Pulmonary Drug Delivery Devices & Systems Sales Quantity by Country (2019-2024) & (K Units)
Table 88. Europe Pulmonary Drug Delivery Devices & Systems Sales Quantity by Country (2025-2030) & (K Units)
Table 89. Europe Pulmonary Drug Delivery Devices & Systems Consumption Value by Country (2019-2024) & (USD Million)
Table 90. Europe Pulmonary Drug Delivery Devices & Systems Consumption Value by Country (2025-2030) & (USD Million)
Table 91. Asia-Pacific Pulmonary Drug Delivery Devices & Systems Sales Quantity by Type (2019-2024) & (K Units)
Table 92. Asia-Pacific Pulmonary Drug Delivery Devices & Systems Sales Quantity by Type (2025-2030) & (K Units)
Table 93. Asia-Pacific Pulmonary Drug Delivery Devices & Systems Sales Quantity by Application (2019-2024) & (K Units)
Table 94. Asia-Pacific Pulmonary Drug Delivery Devices & Systems Sales Quantity by Application (2025-2030) & (K Units)
Table 95. Asia-Pacific Pulmonary Drug Delivery Devices & Systems Sales Quantity by Region (2019-2024) & (K Units)
Table 96. Asia-Pacific Pulmonary Drug Delivery Devices & Systems Sales Quantity by Region (2025-2030) & (K Units)
Table 97. Asia-Pacific Pulmonary Drug Delivery Devices & Systems Consumption Value by Region (2019-2024) & (USD Million)
Table 98. Asia-Pacific Pulmonary Drug Delivery Devices & Systems Consumption Value by Region (2025-2030) & (USD Million)
Table 99. South America Pulmonary Drug Delivery Devices & Systems Sales Quantity by Type (2019-2024) & (K Units)
Table 100. South America Pulmonary Drug Delivery Devices & Systems Sales Quantity by Type (2025-2030) & (K Units)
Table 101. South America Pulmonary Drug Delivery Devices & Systems Sales Quantity by Application (2019-2024) & (K Units)
Table 102. South America Pulmonary Drug Delivery Devices & Systems Sales Quantity by Application (2025-2030) & (K Units)
Table 103. South America Pulmonary Drug Delivery Devices & Systems Sales Quantity by Country (2019-2024) & (K Units)
Table 104. South America Pulmonary Drug Delivery Devices & Systems Sales Quantity by Country (2025-2030) & (K Units)
Table 105. South America Pulmonary Drug Delivery Devices & Systems Consumption Value by Country (2019-2024) & (USD Million)
Table 106. South America Pulmonary Drug Delivery Devices & Systems Consumption Value by Country (2025-2030) & (USD Million)
Table 107. Middle East & Africa Pulmonary Drug Delivery Devices & Systems Sales Quantity by Type (2019-2024) & (K Units)
Table 108. Middle East & Africa Pulmonary Drug Delivery Devices & Systems Sales Quantity by Type (2025-2030) & (K Units)
Table 109. Middle East & Africa Pulmonary Drug Delivery Devices & Systems Sales Quantity by Application (2019-2024) & (K Units)
Table 110. Middle East & Africa Pulmonary Drug Delivery Devices & Systems Sales Quantity by Application (2025-2030) & (K Units)
Table 111. Middle East & Africa Pulmonary Drug Delivery Devices & Systems Sales Quantity by Region (2019-2024) & (K Units)
Table 112. Middle East & Africa Pulmonary Drug Delivery Devices & Systems Sales Quantity by Region (2025-2030) & (K Units)
Table 113. Middle East & Africa Pulmonary Drug Delivery Devices & Systems Consumption Value by Region (2019-2024) & (USD Million)
Table 114. Middle East & Africa Pulmonary Drug Delivery Devices & Systems Consumption Value by Region (2025-2030) & (USD Million)
Table 115. Pulmonary Drug Delivery Devices & Systems Raw Material
Table 116. Key Manufacturers of Pulmonary Drug Delivery Devices & Systems Raw Materials
Table 117. Pulmonary Drug Delivery Devices & Systems Typical Distributors
Table 118. Pulmonary Drug Delivery Devices & Systems Typical Customers
List of Figures
Figure 1. Pulmonary Drug Delivery Devices & Systems Picture
Figure 2. Global Pulmonary Drug Delivery Devices & Systems Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Pulmonary Drug Delivery Devices & Systems Consumption Value Market Share by Type in 2023
Figure 4. Metered Dose Inhalers Examples
Figure 5. Dry Powder Inhalers Examples
Figure 6. Nebulizers Examples
Figure 7. Accessories Examples
Figure 8. Global Pulmonary Drug Delivery Devices & Systems Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 9. Global Pulmonary Drug Delivery Devices & Systems Consumption Value Market Share by Application in 2023
Figure 10. Hospitals and Clinics Examples
Figure 11. Homecare Examples
Figure 12. Global Pulmonary Drug Delivery Devices & Systems Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 13. Global Pulmonary Drug Delivery Devices & Systems Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 14. Global Pulmonary Drug Delivery Devices & Systems Sales Quantity (2019-2030) & (K Units)
Figure 15. Global Pulmonary Drug Delivery Devices & Systems Average Price (2019-2030) & (USD/Unit)
Figure 16. Global Pulmonary Drug Delivery Devices & Systems Sales Quantity Market Share by Manufacturer in 2023
Figure 17. Global Pulmonary Drug Delivery Devices & Systems Consumption Value Market Share by Manufacturer in 2023
Figure 18. Producer Shipments of Pulmonary Drug Delivery Devices & Systems by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 19. Top 3 Pulmonary Drug Delivery Devices & Systems Manufacturer (Consumption Value) Market Share in 2023
Figure 20. Top 6 Pulmonary Drug Delivery Devices & Systems Manufacturer (Consumption Value) Market Share in 2023
Figure 21. Global Pulmonary Drug Delivery Devices & Systems Sales Quantity Market Share by Region (2019-2030)
Figure 22. Global Pulmonary Drug Delivery Devices & Systems Consumption Value Market Share by Region (2019-2030)
Figure 23. North America Pulmonary Drug Delivery Devices & Systems Consumption Value (2019-2030) & (USD Million)
Figure 24. Europe Pulmonary Drug Delivery Devices & Systems Consumption Value (2019-2030) & (USD Million)
Figure 25. Asia-Pacific Pulmonary Drug Delivery Devices & Systems Consumption Value (2019-2030) & (USD Million)
Figure 26. South America Pulmonary Drug Delivery Devices & Systems Consumption Value (2019-2030) & (USD Million)
Figure 27. Middle East & Africa Pulmonary Drug Delivery Devices & Systems Consumption Value (2019-2030) & (USD Million)
Figure 28. Global Pulmonary Drug Delivery Devices & Systems Sales Quantity Market Share by Type (2019-2030)
Figure 29. Global Pulmonary Drug Delivery Devices & Systems Consumption Value Market Share by Type (2019-2030)
Figure 30. Global Pulmonary Drug Delivery Devices & Systems Average Price by Type (2019-2030) & (USD/Unit)
Figure 31. Global Pulmonary Drug Delivery Devices & Systems Sales Quantity Market Share by Application (2019-2030)
Figure 32. Global Pulmonary Drug Delivery Devices & Systems Consumption Value Market Share by Application (2019-2030)
Figure 33. Global Pulmonary Drug Delivery Devices & Systems Average Price by Application (2019-2030) & (USD/Unit)
Figure 34. North America Pulmonary Drug Delivery Devices & Systems Sales Quantity Market Share by Type (2019-2030)
Figure 35. North America Pulmonary Drug Delivery Devices & Systems Sales Quantity Market Share by Application (2019-2030)
Figure 36. North America Pulmonary Drug Delivery Devices & Systems Sales Quantity Market Share by Country (2019-2030)
Figure 37. North America Pulmonary Drug Delivery Devices & Systems Consumption Value Market Share by Country (2019-2030)
Figure 38. United States Pulmonary Drug Delivery Devices & Systems Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Canada Pulmonary Drug Delivery Devices & Systems Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Mexico Pulmonary Drug Delivery Devices & Systems Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Europe Pulmonary Drug Delivery Devices & Systems Sales Quantity Market Share by Type (2019-2030)
Figure 42. Europe Pulmonary Drug Delivery Devices & Systems Sales Quantity Market Share by Application (2019-2030)
Figure 43. Europe Pulmonary Drug Delivery Devices & Systems Sales Quantity Market Share by Country (2019-2030)
Figure 44. Europe Pulmonary Drug Delivery Devices & Systems Consumption Value Market Share by Country (2019-2030)
Figure 45. Germany Pulmonary Drug Delivery Devices & Systems Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. France Pulmonary Drug Delivery Devices & Systems Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. United Kingdom Pulmonary Drug Delivery Devices & Systems Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Russia Pulmonary Drug Delivery Devices & Systems Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Italy Pulmonary Drug Delivery Devices & Systems Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Asia-Pacific Pulmonary Drug Delivery Devices & Systems Sales Quantity Market Share by Type (2019-2030)
Figure 51. Asia-Pacific Pulmonary Drug Delivery Devices & Systems Sales Quantity Market Share by Application (2019-2030)
Figure 52. Asia-Pacific Pulmonary Drug Delivery Devices & Systems Sales Quantity Market Share by Region (2019-2030)
Figure 53. Asia-Pacific Pulmonary Drug Delivery Devices & Systems Consumption Value Market Share by Region (2019-2030)
Figure 54. China Pulmonary Drug Delivery Devices & Systems Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Japan Pulmonary Drug Delivery Devices & Systems Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Korea Pulmonary Drug Delivery Devices & Systems Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. India Pulmonary Drug Delivery Devices & Systems Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Southeast Asia Pulmonary Drug Delivery Devices & Systems Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Australia Pulmonary Drug Delivery Devices & Systems Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. South America Pulmonary Drug Delivery Devices & Systems Sales Quantity Market Share by Type (2019-2030)
Figure 61. South America Pulmonary Drug Delivery Devices & Systems Sales Quantity Market Share by Application (2019-2030)
Figure 62. South America Pulmonary Drug Delivery Devices & Systems Sales Quantity Market Share by Country (2019-2030)
Figure 63. South America Pulmonary Drug Delivery Devices & Systems Consumption Value Market Share by Country (2019-2030)
Figure 64. Brazil Pulmonary Drug Delivery Devices & Systems Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Argentina Pulmonary Drug Delivery Devices & Systems Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 66. Middle East & Africa Pulmonary Drug Delivery Devices & Systems Sales Quantity Market Share by Type (2019-2030)
Figure 67. Middle East & Africa Pulmonary Drug Delivery Devices & Systems Sales Quantity Market Share by Application (2019-2030)
Figure 68. Middle East & Africa Pulmonary Drug Delivery Devices & Systems Sales Quantity Market Share by Region (2019-2030)
Figure 69. Middle East & Africa Pulmonary Drug Delivery Devices & Systems Consumption Value Market Share by Region (2019-2030)
Figure 70. Turkey Pulmonary Drug Delivery Devices & Systems Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Egypt Pulmonary Drug Delivery Devices & Systems Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Saudi Arabia Pulmonary Drug Delivery Devices & Systems Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. South Africa Pulmonary Drug Delivery Devices & Systems Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Pulmonary Drug Delivery Devices & Systems Market Drivers
Figure 75. Pulmonary Drug Delivery Devices & Systems Market Restraints
Figure 76. Pulmonary Drug Delivery Devices & Systems Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Pulmonary Drug Delivery Devices & Systems in 2023
Figure 79. Manufacturing Process Analysis of Pulmonary Drug Delivery Devices & Systems
Figure 80. Pulmonary Drug Delivery Devices & Systems Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Hovione 3M Health Care Bespak BeyonDevices GlaxoSmithKline H&T Presspart PARI Respiratory Equipment Philips Respironics SHL
18 Jan 2023
Medical Devices & Consumables
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
